Investment House LLC raised its position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 17.7% in the 3rd quarter, HoldingsChannel reports. The fund owned 54,167 shares of the financial services provider’s stock after purchasing an additional 8,130 shares during the period. Investment House LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $6,605,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently bought and sold shares of the company. Schroder Investment Management Group acquired a new position in iShares Nasdaq Biotechnology ETF in the 2nd quarter valued at approximately $105,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new position in iShares Nasdaq Biotechnology ETF in the 2nd quarter valued at approximately $134,000. KHP Capital LLC raised its holdings in iShares Nasdaq Biotechnology ETF by 61.1% in the 2nd quarter. KHP Capital LLC now owns 1,450 shares of the financial services provider’s stock valued at $159,000 after acquiring an additional 550 shares in the last quarter. Private Wealth Advisors Inc. acquired a new position in iShares Nasdaq Biotechnology ETF in the 2nd quarter valued at approximately $201,000. Finally, Valmark Advisers Inc. acquired a new position in iShares Nasdaq Biotechnology ETF in the 2nd quarter valued at approximately $202,000. 65.70% of the stock is owned by hedge funds and other institutional investors.
iShares Nasdaq Biotechnology ETF stock traded up $0.31 during trading hours on Tuesday, hitting $115.96. The stock had a trading volume of 33,939 shares, compared to its average volume of 2,529,570. iShares Nasdaq Biotechnology ETF has a fifty-two week low of $100.22 and a fifty-two week high of $122.97.
The business also recently announced a quarterly dividend, which was paid on Tuesday, October 2nd. Stockholders of record on Thursday, September 27th were issued a $0.0324 dividend. The ex-dividend date of this dividend was Wednesday, September 26th. This represents a $0.13 dividend on an annualized basis and a dividend yield of 0.11%.
iShares Nasdaq Biotechnology ETF Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Further Reading: Investing in Dividend Stocks
Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).
Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.